# CEREVEL THERAPEUTICS HLDNG I (CERE)

> Institutional ownership reported to the SEC as of Q3 2024, from Form 13F filings. Source: https://holderbook.com/stocks/CERE/

- Reporting holders: 2
- Reported value: $20.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $15.5K | 346 | 0.0% | 3 |
| [Blue Trust, Inc.](https://holderbook.com/funds/1856022-blue-trust-inc/) | $5.2K | 126 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 240 | $6.8B |
| Q1 2024 | 217 | $6.8B |
| Q4 2023 | 204 | $6.8B |
| Q3 2023 | 126 | $3.1B |
| Q2 2023 | 130 | $4.5B |
| Q1 2023 | 123 | $3.9B |
| Q4 2022 | 134 | $4.3B |
| Q3 2022 | 121 | $3.8B |
| Q2 2022 | 113 | $3.3B |
| Q1 2022 | 109 | $4.3B |
| Q4 2021 | 109 | $4.0B |